Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens

This study has been withdrawn prior to enrollment.
(Study never submitted to IND. Study is being sponsored by Johnson and Johnson in the EU only.)
Sponsor:
Information provided by:
Millennium Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00610792
First received: January 28, 2008
Last updated: July 13, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)